REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot1373Original ArticleEvolution from import substitution to expansion into the foreign marketsArticleEditorialnoemail@neicon.ru1512201813S22422518032022Copyright © 2018,2018The past year exploded with important news from Sotex. First, the purchase of the largest pharmaceutical complex Rafarma JSC by Protek Group. Then, reports on the successful entry into the EU market, the participation of the Russian manufacturer in the key industry events of the European pharmaceutical industry, and the announcement of large-scale international expansion plans. And at the same time, active operations on localization of foreign manufacture on the territory of Russia, competent alignment of the partner relations with the largest players of the world pharma. Our questions about the development strategy of the company were answered by Vadim Yatsuk, Director General, Sotex PharmFirm CJSC.GMPSoteximport substitutionимпортозамещениеСотекс